Goodwin advised Xeris Pharmaceuticals on the deal Xeris Pharmaceuticals (“XERS”), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
